Jan 14, 2016: Kuehne + Nagel and GlaxoSmithKline (GSK) signed an end-to-end global logistics partnership until 2021 that will see Kuehne + Nagel run the core business of transporting products from the raw materials supplier to trade customers for the leading global healthcare company.
The contract will bring significant logistics alignment between the two companies.
Kuehne + Nagel was selected as a partner due to the company’s existing track record with GSK, strength in the industry, maturity of Integrated Logistics provision and significant investment strategy in pharmaceuticals and consumer products logistics.
Detlef Trefzger, chief executive officer of Kuehne + Nagel International AG, stated, “We are very excited about this long term collaboration with GSK. Our focus is to leverage existing experience and industry-specific solutions serving the pharmaceutical and consumer sector which will deliver incremental benefits to GSK. Our integrated logistics approach, comprising air, sea, overland services and Logistics Control Centres in four regional hubs will enable GSK’s global supply chains to move to the next level of performance.”
The new working relationship is a transformational development for GSK and Kuehne + Nagel in its scale and ambition.
With over 66,000 employees at more than 1000 locations in over 100 countries, the Kuehne + Nagel Group is one of the world’s leading logistics companies. Its strong market position lies in the seafreight, airfreight, contract logistics and overland businesses, with a clear focus on providing IT-based integrated logistics solutions.